search

Active clinical trials for "Urinary Bladder Neoplasms"

Results 1171-1180 of 1252

uPAR PET/CT and FDG PET/MRI for Preoperative Staging of Bladder Cancer

Urinary Bladder Neoplasms

The sensitivity and specificity of uPAR PET/CT with the radioligand 68GaNOTA-AE105 and FDG PET/MRI for preoperative detection of regional lymph node metastases in urinary bladder cancer

Unknown status9 enrollment criteria

Validation of a Urine-based Assay With Genomic Markers for Predicting Recurrence for Non-muscle...

Non-muscle Invasive Bladder Cancer

A study to validate, in a prospective manner, the ability of the predefined Genomic Health bladder cancer assay to detect recurrence in patients undergoing surveillance for non-muscle invasive bladder cancer.

Completed5 enrollment criteria

Cystoscopic Imaging Collection and Enhancement pROject

Urinary Bladder Neoplasms

This study will collect video recordings of routine flexible cystoscopy examinations, medical history and diagnosis information, from up to 100 participants who have a history of bladder cancer, or symptoms suggestive of bladder cancer, in order to develop a new computer system for recording and reviewing images of the bladder, and to assess the utility of this system.

Completed4 enrollment criteria

Detecting Bladder Cancer Using the UroMark Test.

Bladder Cancer

DETECT I is a prospective multicentre observational diagnostic study to assess the performance of the UroMark assay to rule out bladder cancer in patients with haematuria. The study will recruit consecutive patients attending haematuria clinics as well as patients referred to urology outpatient clinics for investigation of haematuria. Consenting patients will be provided with a urine sample collection kit and asked to provide a urine sample. An additional urine sample for control assay testing will be provided after the clinic attendance.

Completed5 enrollment criteria

The Accuracy of Optic Biopsies Versus Conventional Biopsies for the Diagnosis of Superficial Bladder...

Bladder Cancer

This study evaluates the accuracy of Confocal Laser Endomicroscopy (CLE) in the diagnostic of non-invasive flat and exophytic bladder neoplasia. CLE results are compared to histopathology results.

Unknown status8 enrollment criteria

Follow-Up of Bladder Cancer Patients From the New England Study of Environment and Health

Bladder Cancer

Background: Bladder cancer often recurs after treatment and patient survival varies greatly. More knowledge is needed about factors that can help identify patients who are at greater risk of disease recurrence and progression to minimize the need for screening and to help guide treatment. The New England Study of Environment and Health (NESEH), conducted by the departments of health in Maine, New Hampshire and Vermont, the Dartmouth Medical School and the NIH, examined the relationship between health and environmental factors such as smoking, diet and water quality in New England. This study provides an opportunity to learn more about patients with bladder cancer. Before launching a full-scale follow-up study on bladder cancer, it is necessary to determine the feasibility of obtaining needed follow-up information from patients enrolled in the NESEH. Objectives: -To determine the completeness and quality of information about treatment, recurrence, and progression that can be obtained for patients from their medical records. Eligibility: -Participants from the NESEH study who are residents of Maine and who were diagnosed with bladder cancer between 2001 and 2003. Design: Determine the vital status of NESEH bladder cancer patients. Select a sample of 40 living and 18 deceased patients. Interview patients or their next of kin by telephone for about 30 to 45 minutes to update exposure information, obtain names and addresses of all hospitals and physicians they have seen since diagnosis, and obtain authorization to access medical records. Obtain and abstract medical records.

Completed6 enrollment criteria

Observational Study of Subjects Having Routine Recurrence Screening for Bladder Cancer

Bladder Cancer Recurrence

The purpose of this study is to detect recurrent bladder cancer using a combination of protein and DNA biomarkers in urine

Completed10 enrollment criteria

Feasibility Evaluation of Magnetic Resonance Imaging and Positron Emission Tomography for Bladder...

Bladder CancerTransitional Cell Carcinoma

The purpose of this study is to to find out if the MRI and PET scans can truly stage patients with bladder cancer. Both scans use newer ways to find out if your disease has grown beyond the bladder. The radioactive tracer used for the PET scan is called C-11 Acetate. We want to see if PET scan will be able to take a picture of the inside of your body that is better than other scans such as the CT scan and MRI. Therefore, the findings of the PET scan will be compared with other imaging studies as well as the surgical findings.

Completed10 enrollment criteria

Cone Beam CT Scanning in Lung and Bladder Cancer.

Lung NeoplasmSmall Cell Carcinoma1 more

To study changes in tumor and normal organ size and/or position which occur during a course of radiation treatments.

Completed18 enrollment criteria

Neutrophils to Lymphocytes Ratio in Predicting the Response to BCG in Non-muscle Invasive Bladder...

Urinary Bladder CancerUrinary Bladder Neoplasm3 more

There is a relation between inflammatory cells and the prognosis of tumors (cancer colon, renal, liver, and urinary bladder). In this study, the investigators will link the Neutrophils to Lymphocytes ratio to the response to intravesical BCG therapy post trans-urethral resection of urinary bladder tumors for the non-invasive urinary bladder tumors.

Completed9 enrollment criteria
1...117118119...126

Need Help? Contact our team!


We'll reach out to this number within 24 hrs